ADRDA logo

Adherium ASX:ADRDA Stock Report

Last Price

AU$0.031

Market Cap

AU$10.3m

7D

14.8%

1Y

n/a

Updated

14 Dec, 2023

Data

Company Financials +

ADRDA Stock Overview

Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. More details

ADRDA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Adherium Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Adherium
Historical stock prices
Current Share PriceAU$0.031
52 Week HighAU$0.033
52 Week LowAU$0.025
Beta2.4
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO24.00%

Recent News & Updates

Recent updates

Shareholder Returns

ADRDAAU Healthcare ServicesAU Market
7D14.8%-6.7%-1.7%
1Yn/a145.4%10.5%

Return vs Industry: Insufficient data to determine how ADRDA performed against the Australian Healthcare Services industry.

Return vs Market: Insufficient data to determine how ADRDA performed against the Australian Market.

Price Volatility

Is ADRDA's price volatile compared to industry and market?
ADRDA volatility
ADRDA Average Weekly Movementn/a
Healthcare Services Industry Average Movement10.8%
Market Average Movement8.2%
10% most volatile stocks in AU Market17.4%
10% least volatile stocks in AU Market3.1%

Stable Share Price: ADRDA has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ADRDA's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aRick Legleiterwww.adherium.com

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution.

Adherium Limited Fundamentals Summary

How do Adherium's earnings and revenue compare to its market cap?
ADRDA fundamental statistics
Market capAU$10.34m
Earnings (TTM)-AU$9.86m
Revenue (TTM)AU$3.20m

3.2x

P/S Ratio

-1.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ADRDA income statement (TTM)
RevenueAU$3.20m
Cost of RevenueAU$670.00k
Gross ProfitAU$2.53m
Other ExpensesAU$12.38m
Earnings-AU$9.86m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.03
Gross Margin79.03%
Net Profit Margin-308.54%
Debt/Equity Ratio0%

How did ADRDA perform over the long term?

See historical performance and comparison